Wave Life Sciences (NASDAQ:WVE) is a biotechnology company focused on advancing the field of genetic medicines. Its operations revolve around developing innovative therapies using its proprietary chemistry platform, aimed at addressing unmet medical needs in various diseases. The company's projects include research and development in areas such as neuromuscular diseases, central nervous system disorders, and genetic skin diseases, with the objective of creating a pipeline of transformative drugs. Through collaboration and rigorous science, Wave Life Sciences aims to deliver life-changing treatments to patients worldwide. Wave Life Sciences is currently traded exclusively on the NASDAQ under the symbol WVE.